Dr. Mohamad Khawandanah’s Medical Training
About Mohamad Khawandanah
A certified physician with the American Board of Internal Medicine, Dr. Mohamad Khawandanah laid the foundation for his career with a bachelor of medicine, bachelor of surgery (MBBS) from the University of Jordan School of Medicine in Amman, Jordan. Shortly before graduation, he augmented his MBBS with a hematology elective and a transplant elective at Cornell University’s Joan and Sanford I. Weill Medical College in New York City. Dr. Mohamad Khawandanah went on to serve a rotating clinical internship at the King Abdul Aziz Hospital and Oncology Center in Jeddah, Saudi Arabia.
After passing his USMLE examinations, Dr. Mohamad Khawandanah undertook a residency in internal medicine and a fellowship in hematology/oncology at the University of Oklahoma Health Science Center (OUHSC) in Oklahoma City. In June 2014, Dr. Khawandanah finished his OUHSC fellowship where he was the chief fellow during the academic year of 2013/2014. He is now an assistant professor of medicine at the University of Oklahoma and sees patients at the Stephenson Cancer Center.
Potentially Curative Surgical Procedures for Pancreatic Cancer
As an accomplished oncologist, Dr. Mohamad Khawandanah has conducted extensive research and presented his findings on surgical treatment outcomes for borderline resectable pancreatic cancer. Dr. Mohamad Khawandanah currently as an Assistant Professor of Medicine in the hematology and oncology section at the University of Oklahoma Health Sciences Center.
In most cases of pancreatic cancer, physicians perform surgery either to attempt a cure or to ease the patient's quality of life. Potentially curative surgery typically involves the removal of the tumor, a procedure known as resection. These procedures are most common in cancers present in the head of the pancreas, where resultant symptoms are more likely to lead to a diagnosis before the cancer spreads.
In these cases, a surgeon may perform a pancreaticoduodenectomy, or whipple procedure. During this procedure, a surgeon removes the head and occasionally the body of the pancreas, along with certain neighboring structures. This particular surgery allows enough of the pancreas to remain to produce insulin and digestive enzymes.
In some situations, the surgeon needs to remove the entire pancreas in a procedure known as a total pancreatectomy, which also requires removal of the spleen. Because this leaves a patient dependent on insulin shots and enzyme pills, most surgeons will not perform it for exocrine tumors. A distal pancreatectomy removes the lower area of the pancreas and the spleen, but because most tumors in this region have spread by the time of diagnosis, this procedure is only beneficial in certain cases.